BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amarin Corporation PLC 

First Floor, Block 3
The Oval
Shelbourne Road

Ballsbridge  Dublin  W1J 5HG  Ireland
Phone: 353-01-6699020 Fax: 353-01-6699028


SEARCH JOBS





Segment
Pharmaceuticals





 Company News
Wall Street Overreacting To Amarin (AMRN) Denial: Citigroup Analyst 9/12/2014 5:07:55 PM
Amarin Corporation PLC (AMRN) Reports First Quarter 2014 Financial Results And Provides Update On Operations 5/9/2014 9:07:45 AM
Amarin Corporation PLC (AMRN) To Report First Quarter 2014 Results And Host Conference Call On May 9, 2014 5/5/2014 8:59:09 AM
Amarin Corporation PLC (AMRN) Announces Presentation Of New MARINE And ANCHOR Post-Hoc Analyses At National Lipid Association Annual Scientific Sessions Showing Vascepa® Significantly Reduced Apolipoprotein C-III Levels 5/2/2014 9:44:25 AM
Amarin Corporation PLC (AMRN) And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules 4/1/2014 11:05:15 AM
Amarin Corporation PLC (AMRN) Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Update On Operations 2/28/2014 9:22:12 AM
Amarin Corporation PLC (AMRN) Announces FDA Award Of Three-Year Exclusivity For Vascepa® (Icosapent Ethyl) Capsules 2/24/2014 9:01:39 AM
Amarin Corporation PLC (AMRN) To Report Fourth Quarter And Year-End 2013 Results And Host Conference Call On February 27, 2014 2/24/2014 8:54:15 AM
Amarin Corporation PLC (AMRN) To Present At The 2014 Leerink Swann and Company Global Healthcare Conference 2/6/2014 9:07:23 AM
Amarin Corporation PLC (AMRN) Announces Promotion Of Aaron Berg To Senior Vice President, Marketing And Sales 2/4/2014 9:15:05 AM
12345678910...